Avodart (Dutasteride) Cost in Arizona 2026: Prices, Insurance, and Savings
Current dutasteride and Avodart prices in Arizona for 2026, including cash-pay, insurance, Medicaid, compounded options, and discount programs.
77 source-based articles maintained by the HealthRX.com Editorial Team.

Showing 77 of 77 clinical reviews.
Current dutasteride and Avodart prices in Arizona for 2026, including cash-pay, insurance, Medicaid, compounded options, and discount programs.
Current dutasteride and Avodart pricing in Ohio for 2026, including cash-pay, Medicaid, insurance coverage, compounded options, and discount programs.
Evidence-based guide to dutasteride 0.5 mg dosing in adults aged 65 and older, covering pharmacokinetics, BPH efficacy, renal considerations, drug interactions, and deprescribing.
A clinical guide to dutasteride (Avodart) monitoring in adults 65 and older, covering falls risk, renal considerations, drug interactions, PSA interpretation, and deprescribing thresholds.
A guide to dutasteride (Avodart) monitoring protocols for men and women aged 50 to 64, covering PSA interpretation, cardiovascular checks, hormone interactions, and safety labs at each follow-up visit.
A guide to dutasteride's off-label applications beyond BPH, including androgenetic alopecia, hirsutism, and prostate cancer chemoprevention, with evidence grades and cited clinical trials.
A guide to dutasteride (Avodart) safety in children under 12, covering FDA labeling, hormonal risks, accidental exposure, and why the drug is contraindicated in pediatric populations.
A clinician-level review of dutasteride (Avodart) regulatory approvals across the US, EU, Canada, and UK, including BPH indications, off-label hair loss use, and key differences between jurisdictions.
A guide to dutasteride (Avodart) safety in adults aged 30, 49, covering sexual side effects, cardiovascular signals, cancer risk, drug interactions, and how to weigh risks against benefits for BPH and hair loss.
A guide to dutasteride safety in young adults ages 18, 29, covering sexual side effects, fertility, mental health signals, contraindications, and monitoring protocols with primary-source citations.
Complete dutasteride dosing guide for adults aged 30-49, covering FDA-approved BPH doses, off-label hair loss use, clinical trial data, and practical management tips for men in their peak working years.
Complete 2026 guide to Avodart and generic dutasteride costs in Delaware, including Medicaid coverage, compounded options, telehealth access, and verified discount programs with clinical references.
Find out exactly how much Avodart (dutasteride) costs in Louisiana in 2026, which insurance plans and Medicaid cover it, whether compounded dutasteride is legal, and the fastest ways to lower your out-of-pocket cost.
The complete 2026 guide to dutasteride (Avodart) cost in New Mexico, including cash prices, Medicaid coverage, compounded dutasteride legality, telehealth access, and how to use GoodRx or manufacturer savings cards.
How much does Avodart cost in New York in 2026? Brand, generic, and compounded dutasteride prices, Medicaid coverage rules, insurance PA requirements, and telehealth options explained.
How much does Avodart (dutasteride) cost in Oklahoma in 2026? Compare cash-pay prices, generic options, Oklahoma Medicaid coverage, compounded dutasteride legality, and telehealth access in one guide.
Find out exactly what Avodart (dutasteride) costs in Texas in 2026, including cash-pay prices, generic options, compounded dutasteride, Medicaid coverage rules, and telehealth access. Reviewed by HealthRX.com physicians.
Compare the cost of dutasteride (Avodart) against finasteride, tamsulosin, and combination therapies for BPH and hair loss. Includes generic pricing, insurance coverage, and clinical value analysis.
A clinician-level review of dutasteride (Avodart) dosing in renal impairment, covering pharmacokinetics, mechanism of action, trial data, and practical prescribing guidance.
A guide to dutasteride (Avodart) safety in men aged 65 and older, covering renal function, falls risk, drug interactions, cardiovascular signals, and deprescribing criteria.
A clinical history of dutasteride (Avodart), from GSK's dual 5-alpha reductase inhibitor development through FDA approval for BPH and its off-label rise in androgenetic alopecia treatment.
Avodart (dutasteride) info for ages 50-64: half-life, DHT suppression, REDUCE trial prostate cancer data, sexual side effects, and drug interaction risks.
A clinical review of dutasteride (Avodart) manufacturing, GSK production history, soft gelatin capsule supply challenges, generic market entry, and documented shortage events.
A detailed look at dutasteride (Avodart) patent expiry dates, Paragraph IV challenges, generic approvals, and what the post-exclusivity market means for BPH and hair loss patients.
A clinical deep-dive into dutasteride (Avodart) pharmacokinetics covering absorption, distribution, metabolism, elimination, its 5-week half-life, CYP3A4 metabolism, and DHT suppression kinetics.
Complete guide to dutasteride (Avodart) storage conditions, shelf-life data, chemical stability, and what happens when capsules are exposed to heat, moisture, or light, with PubMed and FDA citations.
A guide to dutasteride (Avodart) monitoring for men aged 18 to 29, covering labs, fertility, sexual side effects, PSA interpretation, and when to stop treatment.
A complete guide to Aetna's Avodart coverage rules, prior-authorization criteria, step-therapy requirements, formulary tiers, and how to appeal a denial, with real costs and clinical evidence.
Anthem (Elevance Health) covers dutasteride (Avodart) for BPH with prior authorization and step therapy. Learn formulary tier, PA criteria, appeal steps, and cost-saving alternatives.
Find out whether Cigna covers Avodart (dutasteride) for BPH and hair loss, what prior-authorization criteria apply, how step therapy works, and how to appeal a denial.
A guide to Kaiser Permanente formulary status, prior authorization requirements, step therapy, appeals, and cash-pay alternatives for Avodart (dutasteride) in 2025.
State Medicaid coverage for Avodart (dutasteride) varies widely. Learn formulary status, prior authorization requirements, step therapy rules, and how to appeal a denial.
TRICARE covers generic dutasteride on its formulary for BPH, but brand-name Avodart may require prior authorization. Learn about formulary tiers, step therapy, appeal processes, and cost-saving strategies for military beneficiaries.
UnitedHealthcare typically covers Avodart (dutasteride) on Tier 3 with prior authorization for BPH. Learn formulary placement, PA criteria, step therapy rules, appeal steps, and cost-saving alternatives.
A guide to dutasteride dosing considerations for adolescents ages 12 to 17, covering FDA approval status, off-label use evidence, safety monitoring, and clinical decision frameworks.
Evidence-based guide to dutasteride pharmacokinetics, CYP3A4 metabolism, and dose considerations in patients with liver disease. Includes FDA label gaps, clinical reasoning, and monitoring strategies.
Evidence-based guide to dutasteride food and supplement interactions, including saw palmetto, St. John's wort, grapefruit, and fat-soluble vitamin concerns.
A clinician-level review of dutasteride pipeline developments, novel delivery systems, combination therapies, and emerging indications beyond BPH and androgenetic alopecia.
Evidence-based guide to prescribing dutasteride in transplant recipients, people living with HIV, patients with hepatic or renal impairment, and other special populations. Includes drug interactions, dose adjustments, and monitoring protocols.
Evidence-based guide to handling a missed dose of dutasteride (Avodart). Covers pharmacokinetics, the 5-week half-life advantage, clinical impact, and step-by-step instructions.
Evidence-based monitoring guide for dutasteride (Avodart) in adults aged 30-49, covering PSA adjustments, liver function, hormonal panels, and safety labs for BPH and hair loss.
A clinician-focused guide to dutasteride (Avodart) monitoring protocols for adolescents aged 12, 17, covering growth, hormonal, psychiatric, and laboratory checkpoints with evidence-based dosing context.
Evidence-based monitoring schedule for dutasteride (Avodart), including baseline labs, PSA adjustments, liver function testing, and follow-up exam intervals for BPH and hair loss.
Evidence-based guide to managing dutasteride (Avodart) overdose or accidental double dosing, including pharmacokinetic data, clinical safety margins, and when to seek emergency care.
Evidence-based guide to monitoring dutasteride use in pediatric patients under 12, covering safety parameters, lab schedules, growth tracking, and clinical decision points.
Dutasteride (Avodart) is FDA Pregnancy Category X. This article covers teratogenic risk, blood donation restrictions, partner exposure precautions, lactation data, and clinical guidance for 5-alpha reductase inhibitor use near conception.
A clinician-grade review of dutasteride (Avodart) safety signals, FDA label changes, the REDUCE trial prostate cancer finding, sexual adverse effects, and mental health concerns, with PubMed-cited evidence.
A guide to how dutasteride works, its oral dosing for BPH and hair loss, why no injectable form exists, and what the clinical evidence says about efficacy and safety.
Dutasteride's half-life is 5 weeks at steady state, the longest of any 5-alpha reductase inhibitor. FDA dose is 0.5 mg daily, no age adjustment needed.
Dutasteride interacts most with strong CYP3A4 inhibitors like ketoconazole, raising its levels 2.5-fold. No clinically significant effect on warfarin or digoxin.
A physician-level explanation of how dutasteride (Avodart) works, covering dual 5-alpha reductase inhibition, DHT suppression kinetics, tissue-level effects in prostate and scalp, and how its pharmacology compares to finasteride.
Dutasteride (Avodart) has no FDA-approved pediatric indication for children under 12. Learn why no established dose exists, what the safety concerns are, and what clinical evidence says about 5-alpha reductase inhibitors in young patients.
A clinical deep-dive into how CYP3A4, SRD5A1, SRD5A2, and androgen receptor gene polymorphisms influence dutasteride metabolism, efficacy, and side-effect risk.
A complete clinical guide to obtaining an Avodart (dutasteride) prescription in Alabama, including telehealth options, required labs, pharmacy access, and prior authorization steps.
A guide to obtaining an Avodart (dutasteride) prescription in Arkansas, including telehealth options, lab requirements, pharmacy choices, and prior authorization steps.
A guide to obtaining an Avodart (dutasteride) prescription in Delaware through telehealth or in-person visits, including labs, pharmacy options, prior authorization, and compounding rules.
A guide to obtaining a dutasteride (Avodart) prescription in Florida, including telehealth options, lab requirements, pharmacy rules, and dosing for BPH and hair loss.
A complete guide to getting an Avodart (dutasteride) prescription in Georgia, including telehealth options, lab requirements, pharmacy choices, and cost information.
A complete guide to obtaining an Avodart (dutasteride) prescription in Hawaii, including telehealth options, pharmacy access, lab requirements, prior authorization, and shipping timelines.
A complete guide to getting an Avodart (dutasteride) prescription in Illinois, including telehealth options, required labs, pharmacy access, prior authorization, and compounding via licensed 503A pharmacies.
Showing the first 60 matches. Use search or filters to narrow the library.